Back to Search
ELLEN ROH, MD
MD
Dermatology Physician
NPI: 1598963498IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
MT184158(PA)235796(MA)
CMS Specialties
PrimaryDERMATOLOGY
Education
UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
A new HLA-B*51 variant, B*5158, identified by sequence-based typing in a Korean individual.
PMID 19317751·Tissue Antigens·2009
8-other
Synthesis and nuclear factor-kappaB inhibitory activities of 6- or 7-methylchroman-2-carboxylic acid N-(substituted) phenylamides.
PMID 19280144·Arch Pharm Res·2009
7-preclinical
Diverse Antibacterial activity of Pectobacterium carotovorum subsp.carotovorum isolated in Korea.
PMID 19190407·J Microbiol Biotechnol·2009
8-other
Introducing pulsed low-intensity ultrasound to culturing human umbilical cord-derived mesenchymal stem cells.
PMID 18985278·Biotechnol Lett·2009
8-other
[Complete blood count reference values of donated cord blood from Korean neonates].
PMID 19571613·Korean J Lab Med·2009
8-other
Synthesis of chroman-2-carboxylic acid N-(substituted)phenylamides and their inhibitory effect on nuclear factor-kappaB (NF-kappaB) activation.
PMID 18365680·Arch Pharm Res·2008
7-preclinical
Benzoxathiole derivative blocks lipopolysaccharide-induced nuclear factor-kappaB activation and nuclear factor-kappaB-regulated gene transcription through inactivating inhibitory kappaB kinase beta.
PMID 18202307·Mol Pharmacol·2008
7-preclinical
Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.
PMID 18625556·Bioorg Med Chem Lett·2008
7-preclinical
Genus-specific distribution and pathovar-specific variation of the glycinecin R gene homologs in Xanthomonas genomes.
PMID 19107397·J Microbiol·2008
8-other
Development of selective blockers for Ca²(+)-activated Cl channel using Xenopus laevis oocytes with an improved drug screening strategy.
PMID 18959787·Mol Brain·2008
7-preclinical
Structure-activity relationships of 1,4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1).
PMID 18809334·Bioorg Med Chem·2008
7-preclinical
Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages.
PMID 18573490·Biochem Pharmacol·2008
7-preclinical
Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins.
PMID 18473741·Comb Chem High Throughput Screen·2008
8-other
Comparison of VERSANT Hepatitis B virus DNA 3.0 Assay with Digene Hybrid Capture II Hepatitis B virus DNA test in relation to clinical status of Hepatitis B virus.
PMID 18160836·Korean J Lab Med·2007
4-observational
P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoring.
PMID 17564423·J Med Chem·2007
8-other
A useful predictor of early atherosclerosis in obese children: serum high-sensitivity C-reactive protein.
PMID 17449922·J Korean Med Sci·2007
8-other
Developmental expression of transferrin binding protein in oligodendrocyte lineage cells of the embryonic chick spinal cord.
PMID 17151919·Neurochem Res·2007
7-preclinical
Lead discovery and optimization of T-type calcium channel blockers.
PMID 17150365·Bioorg Med Chem·2007
7-preclinical
Action of nucleosides and nucleotides at 7 transmembrane-spanning receptors.
PMID 17067963·Nucleosides Nucleotides Nucleic Acids·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 50 STANIFORD ST, SUITE 200
BOSTON, MA 02114 - Phone
- (617) 726-2914
Quick Facts
- NPI
- 1598963498
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile